Incyte (INCY) Assets (2010 - 2026)
Incyte's (INCY) quarterly Assets came in at $7.9 billion in Q2 2026, up 35.24% YoY from $5.8 billion in Q2 2025, and up 7.27% on a QoQ basis from $7.3 billion in Q1 2026.
Incyte (INCY) Assets (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Assets data on file, last reported at $7.9 billion in Q2 2026.
- Quarterly Assets rose 35.24% year-over-year to $7.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.9 billion (up 35.24% YoY) and the FY2025 annual result came in at $7.0 billion, up 27.8% from the prior year.
- Assets grew to $7.9 billion in Q2 2026, from $7.3 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $7.9 billion in Q2 2026 to a low of $4.7 billion in Q2 2024.
- A 5-year average of $6.1 billion and a median of $5.8 billion in 2022 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets jumped 38.04% — and 2024, when it retreated 24.91%.
- Tracing INCY's Assets over 5 years: stood at $5.8 billion in 2022, then advanced by 16.11% to $6.8 billion in 2023, then declined by 19.73% to $5.4 billion in 2024, then gained by 27.8% to $7.0 billion in 2025, then gained by 13.15% to $7.9 billion in 2026.
- The last three Assets figures came in at $7.9 billion (Q2 2026), $7.3 billion (Q1 2026), and $7.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | 7.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.87 Bn |
| Mar 31, 2026 | 7.34 Bn |
| Dec 31, 2025 | 6.96 Bn |
| Sep 30, 2025 | 6.33 Bn |
| Jun 30, 2025 | 5.82 Bn |
| Mar 31, 2025 | 5.75 Bn |
| Dec 31, 2024 | 5.44 Bn |
| Sep 30, 2024 | 5.01 Bn |
| Jun 30, 2024 | 4.66 Bn |
| Mar 31, 2024 | 7.14 Bn |
| Dec 31, 2023 | 6.78 Bn |
| Sep 30, 2023 | 6.39 Bn |
| Jun 30, 2023 | 6.21 Bn |
| Mar 31, 2023 | 5.80 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 5.51 Bn |
| Jun 30, 2022 | 5.32 Bn |
| Mar 31, 2022 | 5.05 Bn |
| Dec 31, 2021 | 4.93 Bn |
| Sep 30, 2021 | 4.20 Bn |